Skip to main content
. 2020 Aug 21;34(1):22–27. doi: 10.1080/08998280.2020.1799479

Table 1.

Age, body composition, blood pressure, and metabolic parameters of Mexicans aged 18 to 22 years divided according to the AIPa

Variable Total (n = 1004) Low risk (n = 700) Intermediate risk (n = 137) Increased risk (n = 167) P
Women, n (%) 639 (63%) 471 (67%) 86 (63%) 82 (49%)  
Men, n (%) 385 (37%) 229 (33%) 51 (37%) 85 (51%)  
Age (years) 18.9 ± 2 18.8 ± 1.9 19.1 ± 3.7 19 ± 1.7 0.4
Weight (kg) 64.3 ± 13.6 61.6 ± 12.2b 67.1 ± 13.8b 72.3 ± 15.8 <0.0001
Height (m) 1.64 ± 0.08 1.63 ± 0.08b 1.64 ± 0.07b 1.66 ± 0.09 <0.0001
Waist circumference (cm) 81.4 ± 11.2 80.3 ± 10.1b 86 ± 10.5 86.9 ± 11.7 <0.0001
Hip circumference (cm) 98 ± 8.6 96.7 ± 8.1b 101 ± 8.7 101 ± 9.4 <0.0001
Body mass index (kg/m2) 23.7 ± 4.1 22.9 ± 3.7b 24.8 ± 4.4 25.8 ± 4.5 <0.0001
Fat mass (%) 23.2 ± 7.1 23 ± 7.1 24.8 ± 4.4 25.8 ± 4.4 0.007
Glucose (mg/dL) 89.3 ± 16.6 88.3 ± 17.4b 90.8 ± 14.3 92 ± 14.1 0.009
Total cholesterol (mg/dL) 164.3 ± 38.8 163.5 ± 32.2b 169.3 ± 28.7b 182.6 ± 42.4 <0.0001
Triglycerides (mg/dL) 117.9 ± 55.9 92.3 ± 28.6b 140.6 ± 23.9b 206.7 ± 62 <0.0001
HDL-C (mg/dL) 50.1 ± 13.2 54.5 ± 12.8b 42.6 ± 6.8b 37.7 ± 6.9 <0.0001
LDL-C (mg/dL) 92.9 ± 24.7 89.7 ± 23.8b 97.3 ± 20.7 102.3 ± 28.1 <0.0001
VLDL-C (mg/dL) 23.1 ± 10.8 18.02 ± 5.5b 28 ± 5b 39.9 ± 11.3 <0.0001
Ureic acid (mg/dL) 5.5 ± 1.4 5.3 ± 1.2b 5.8 ± 1.4b 6.1 ± 1.5 <0.0001
Systolic blood pressure (mm Hg) 115.7 ± 13.5 112.3 ± 11.7b 119.1 ± 12.6b 125.2 ± 15.5 <0.0001
Diastolic blood pressure (mm Hg) 70.9 ± 9.4 69.5 ± 9.1b 73.3 ± 10.6 74.3 ± 8.7 0.01
Total cholesterol/HDL-C 3.5 ± 1.2 3 ± 0.6b 4 ± 0.6b 5 ± 1.9 <0.0001
Triglycerides/HDL-C 2.6 ± 1.7 1.7 ± 0.5b 3.2 ± 0.2b 5.6 ± 2.1 <0.0001
LDL-C/HDL-C 2 ± 0.7 1.7 ± 0.5b 2.3 ± 0.5b 2.8 ± 0.9 <0.0001
a

Mean ± standard deviation. Comparison was made by one-way analysis of variance and post hoc Tukey test for independent samples in the continuous quantitative variables.

b

Statistical differences (P < 0.05) vs. increased risk group.

HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol.